Author:
Agapkina Yu. V.,Nikitin A. G.,Brovkin A. N.,Pushkov A. A.,Evdokimova M. A.,Aseycheva O. Yu.,Osmolovskaya V. S.,Minushkina L. O.,Kochkina M. S.,Selezneva N. D.,Dankovtseva E. N.,Chumakova O. S.,Baklanova T. N.,Talyzin P. A.,Reznichenko N. E.,Donetskaya O. P.,Tereschenko S. N.,Krasil’nikova E. S.,Dzhaiani N. A.,Akatova E. V.,Glezer M. G.,Galyavich A. S.,Zakirova V. B.,Koziolova N. A.,Timofeeva I. V.,Yagoda A. V.,Boyeva O. I.,Katelnitskaya L. I.,Horolets E. V.,Shlyk S. V.,Volkova E. G.,Margaryan M. P.,Guz I. O.,Konstantinov V. O.,Timofeyeva A. N.,Sidorenko B. A.,Zateyshchikov D. A.,Nosikov V. V.
Subject
Structural Biology,Biophysics
Reference24 articles.
1. Oganov R.G., Maslennikova G.Ya. 2003. Impact of cardiovascular and other noninfectious diseases on population health in Russia. Serdtse. 2, 58–61.
2. Shevchenko O.P., Mishnev O.D. 2005. Ishemicheskaya bolezn’ serdtsa (Ischemic Heard Disease), Moscow: Reafarm.
3. Goyal A., Blazing M. 2005. Should we measure C-reactive protein levels to ascertain the adequacy of statin therapy in patients who are at very high risk for a coronary heart disease event? Am. Heart J. 150, 650–651.
4. Aronov D.A. 2002. Primary and secondary prophylaxis of cardiovascular diseases: Interpolation to Russia. Serdtse. 3, 109–112.
5. Pratt R.E., Dzau V.J. 1999. Genomics and hypertension: Concepts, potentials, and opportunities. Hypertension. 33, 238–247.